Laborie Medical Technologies Invests in Start-Up Bright Uro

Laborie Medical Technologies Invests in Start-Up Bright Uro

by | Dec 4, 2023 10:37 am | Medical Devices, Private Equity

Laborie Medical Technologies Corp. (LMT) has announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, California. Founded in 2021, Bright Uro is developing the Glean Urodynamic System™, a wireless, catheter-free, urodynamic monitoring system intended to quantify the pressure characteristics of the lower urinary tract.  LMT, a subsidiary of Stockholm-based private equity firm Patricia Industries, is a global medical technology company focused on urology, urogynecology, gastroenterology, obstetrics, gynecology and neonatal health. LMT develops, manufactures and markets medical technology and consumables to diagnose and... Read More »

Arbor Pharma Targets ‘Alcohol Use Disorder’ Drug

by | May 26, 2016 8:00 am | Pharmaceuticals

Specialty pharma company Arbor Pharmaceuticals has acquired XenoPort, Inc. (NASDAQ: XNPT), maker of Horizant, a potential treatment for patients with “alcohol use disorder.” XenoPort develops and commercializes a portfolio of product candidates for the treatment of neurological and other disorders in the United States. The company has entered into a clinical trial agreement with the National Institute on Alcohol Abuse and Alcoholism. Arbor will pay $7.03 per share in cash, or a total equity value of approximately $467 million. Centerview Partners is serving as exclusive financial advisor to XenoPort, and Weil, Gotshal & Manges LLP is serving as legal advisor to XenoPort.... Read More »